SSII · SS Innovations International, Inc. · Executive Compensation
$1.32
-0.19 (-12.58%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$264.51M
Shares
200.39M
Volume · Nov 12
156.39K
Avg daily vol (3M)
66.5K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Sarah M. Romano | Chief Financial Officer | Appointed | 2026-07-14 |
| Milan Rao | Chief Financial Officer | Appointed | 2026-01-08 |
| Milan Rao | Global Chief Operating Officer | Appointed | 2026-01-08 |
| Naveen Kumar Amar | Chief Financial Officer | Resigned | 2026-01-08 |
| Naveen Kumar Amar | Chief Financial Officer | Appointed | 2025-09-26 |
| Arvind Palaniappan | Interim Chief Financial Officer | Resigned | 2025-07-28 |
| Dr. Vishwajyoti P. Srivastava, M.D. | Chief Executive Officer – Asia Pacific | Appointed | 2025-05-23 |
| Arvind Palaniappan | Interim Chief Financial Officer | Appointed | 2025-05-02 |
| Tim Adams | Independent Director | Appointed | 2024-09-30 |
| Fredric Moll | Vice Chairman | Appointed | 2024-09-10 |
| Timothy P. Adams | director | Appointed | 2024-08-22 |
| Dr. Frederic Moll | non-executive Vice Chairman of the Board of Directors | Appointed | 2024-08-22 |
| Dr. Frederic Moll | director | Appointed | 2024-08-22 |
| Prof. Dr. Somashekhar S.P. | director | Appointed | 2023-08-07 |
| Dr. Mylswamy Annadurai | director | Appointed | 2023-08-07 |
| Anup Sethi | Chief Financial Officer | Appointed | 2023-04-19 |
| Dr. Vishwjyoti P. Srivastava | Chief Operating Officer – South Asia | Appointed | 2023-04-19 |
| Dr. Vishwjyoti P. Srivastava | director | Appointed | 2023-04-19 |
| Dr. Sudhir Srivastava | Chief Executive Officer | Appointed | 2023-04-19 |
| Dr. Sudhir Srivastava | Chairman | Appointed | 2023-04-19 |
| Barry F. Cohen | Chief Operating Officer – Americas | Appointed | 2023-04-19 |
| Dr. Sudhir Srivastava | director | Appointed | 2023-04-19 |
| Dr. Ray Powers | Acting Chief Financial Officer | Resigned | 2023-04-19 |
| Dr. Farhan Taghizadeh | Chief Medical Officer | Resigned | 2023-04-19 |
| Barry F. Cohen | Chief Executive Officer | Resigned | 2023-04-19 |
Leadership
- Dr. Sudhir Srivastava CEO, Chairman, Board Member
- Dr. Vishwajyoti P. Srivastava, M.D. CEO
- Sudhir Srivastava CEO, Chairman, Board Member
- Anup Sethi CFO
- Arvind Palaniappan CFO
- Milan Rao CFO, COO
- Naveen Kumar Amar CFO
- Sarah M. Romano CFO
- Barry F. Cohen COO
- Dr. Vishwajyoti P. Srivastava COO, Board Member
- Dr. Vishwjyoti P. Srivastava COO, Board Member
- Dr. Frederic Moll Board Member
- Dr. Fredric Moll Board Member
- Dr. Mylswamy Annadurai Board Member
- Frederic Moll Board Member
- Fredric Moll Board Member
- Prof. Dr. Somashekhar S.P. Board Member
- Tim Adams Board Member
- Timothy P. Adams Board Member
Key facts
CIK
1676163
CUSIP
05453U203
13F (30d)
16 filings
16 filers
Visit website
Investor relations